Key Proteo, a proteomics diagnostics company specializing in the early identification of rare but treatable genetic disorders, is building a new CLIA-certified laboratory as part of its initial commercialization and growth strategy to enhance newborn screening programs.   The CLIA certification process involves passing a series of inspections to ensure that the respective laboratory is properly staffed, equipped and quality-controlled. Additionally, all laboratory personnel must be properly tr...